Tocilizumab in Patients With Schnitzler's Syndrome

NCT03046381 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Schnitzler's Syndrome

Interventions

DRUG: Tocilizumab

Sponsor

Karoline Krause

Collaborators

[object Object]